(Q33951580)

30 July 2017

5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential (English)

1 reference

30 July 2017

Koek W

1

1 reference

30 July 2017

Vacher B

2

1 reference

30 July 2017

Cosi C

3

1 reference

30 July 2017

Assié MB

4

1 reference

30 July 2017

Patoiseau JF

5

1 reference

30 July 2017

Pauwels PJ

6

1 reference

30 July 2017

Colpaert FC

7

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

European Journal of Pharmacology

30 July 2017

1 reference

30 July 2017

420

1 reference

30 July 2017

2-3

1 reference

30 July 2017

103-112

1 reference

Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

Biphasic displacement of [3H]YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsychotics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

Is the forced swimming test a suitable model for revealing antidepressant activity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

Different effects of intracerebral and systemic administration of buspirone in the forced swimming test: involvement of a metabolite.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

The putative <<silent>> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

A review of clinical efficacy of 5-HT 1A agonists in anxiety and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

5-HT1A receptor agonists: recent developments and controversial issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

The measurement of efficacy in the drug discovery agonist selection process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

Antidepressant-like behavioral effects of serotonin receptor agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

Pharmacology of cloned human 5-HT1D receptor-mediated functional responses in stably transfected rat C6-glial cell lines: further evidence differentiating human 5-HT1D and 5-HT1B receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

Stimulated [35S]GTP gamma S binding by 5-HT1A receptor agonists in recombinant cell lines. Modulation of apparent efficacy by G-protein activation state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

Behavioural despair in rats: A new model sensitive to antidepressant treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

Antidepressant-like activity of ipsapirone, buspirone and gepirone in the forced swimming test in rats pretreated with proadifen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

Antidepressant-like activity of compounds with varying efficacy at 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

Characterisation of a cloned human 5-HT1A receptor cell line using [35S]GTP gamma S binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

Design and synthesis of a series of 6-substituted-2-pyridinylmethylamine derivatives as novel, high-affinity, selective agonists at 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

The concept of selectivity in 5-HT receptor research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901011-1

10.1016/S0014-2999(01)01011-1

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference